Addus Homecare Co. (ADUS) Expected to Post Quarterly Sales of $140.27 Million

Analysts expect Addus Homecare Co. (NASDAQ:ADUS) to announce sales of $140.27 million for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Addus Homecare’s earnings. The lowest sales estimate is $137.50 million and the highest is $143.66 million. Addus Homecare reported sales of $111.96 million during the same quarter last year, which indicates a positive year-over-year growth rate of 25.3%. The firm is scheduled to issue its next earnings results on Monday, March 4th.

According to Zacks, analysts expect that Addus Homecare will report full year sales of $518.59 million for the current fiscal year, with estimates ranging from $515.80 million to $521.97 million. For the next financial year, analysts forecast that the business will post sales of $610.64 million, with estimates ranging from $572.95 million to $652.00 million. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that cover Addus Homecare.

Addus Homecare (NASDAQ:ADUS) last posted its earnings results on Tuesday, November 6th. The company reported $0.48 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.40 by $0.08. Addus Homecare had a return on equity of 9.55% and a net margin of 3.25%. The firm had revenue of $137.63 million during the quarter, compared to analyst estimates of $139.43 million.

A number of research analysts have recently commented on the company. Cantor Fitzgerald assumed coverage on Addus Homecare in a report on Wednesday, September 12th. They set an “overweight” rating and a $77.00 price target for the company. BidaskClub lowered Addus Homecare from a “buy” rating to a “hold” rating in a report on Friday, August 17th. Royal Bank of Canada assumed coverage on Addus Homecare in a report on Monday, October 8th. They set an “outperform” rating and a $81.00 price target for the company. Zacks Investment Research lowered Addus Homecare from a “hold” rating to a “strong sell” rating in a report on Monday, October 22nd. Finally, Raymond James assumed coverage on Addus Homecare in a report on Monday, August 20th. They set an “outperform” rating and a $75.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $73.50.

In other news, Director Mark L. First sold 352,400 shares of the business’s stock in a transaction that occurred on Tuesday, November 27th. The stock was sold at an average price of $72.60, for a total transaction of $25,584,240.00. Following the sale, the director now directly owns 19,151 shares in the company, valued at $1,390,362.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Eos Capital Partners Iii L. P sold 540,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $72.46, for a total value of $39,128,400.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 923,400 shares of company stock worth $66,935,850. 34.80% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Eos Management L.P. increased its position in shares of Addus Homecare by 4,991.1% during the third quarter. Eos Management L.P. now owns 190,221,406 shares of the company’s stock valued at $2,712,000 after purchasing an additional 186,485,035 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Addus Homecare by 1.7% during the second quarter. Dimensional Fund Advisors LP now owns 913,787 shares of the company’s stock valued at $52,317,000 after purchasing an additional 15,487 shares during the period. BlackRock Inc. increased its position in shares of Addus Homecare by 24.9% during the third quarter. BlackRock Inc. now owns 731,017 shares of the company’s stock valued at $51,281,000 after purchasing an additional 145,736 shares during the period. Vanguard Group Inc. increased its position in shares of Addus Homecare by 48.5% during the third quarter. Vanguard Group Inc. now owns 544,748 shares of the company’s stock valued at $38,214,000 after purchasing an additional 177,827 shares during the period. Finally, Renaissance Technologies LLC increased its position in shares of Addus Homecare by 47.8% during the third quarter. Renaissance Technologies LLC now owns 271,547 shares of the company’s stock valued at $19,049,000 after purchasing an additional 87,847 shares during the period.

Shares of ADUS stock opened at $74.22 on Monday. Addus Homecare has a 12 month low of $31.20 and a 12 month high of $77.82. The company has a market cap of $972.13 million, a PE ratio of 51.19, a price-to-earnings-growth ratio of 2.94 and a beta of -0.26. The company has a debt-to-equity ratio of 0.37, a current ratio of 4.19 and a quick ratio of 4.19.

About Addus Homecare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Recommended Story: How Investors Use a Balance Sheet

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit